• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情后患者中罕见的危及生命的机会性毛霉菌病风暴:两种病原体的故事

Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.

作者信息

Sannathimmappa Mohan Bilikallahalli, Nambiar Vinod, Aravindakshan Rajeev

机构信息

Department of Microbiology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Andhra Pradesh, India.

Department of Microbiology, National University of Science and Technology, Sohar Campus, Sultanate of Oman.

出版信息

Int J Crit Illn Inj Sci. 2022 Jan-Mar;12(1):38-46. doi: 10.4103/ijciis.ijciis_48_21. Epub 2022 Mar 24.

DOI:10.4103/ijciis.ijciis_48_21
PMID:35433396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9008285/
Abstract

Mucormycosis is a rare but life-threatening opportunistic fungal infection caused by a group of molds that belong to Zygomycetes of the order Mucorales. These fungi are found in the environment such as soil, decaying vegetation, and organic matters. Sporangiospores present in the environment enter the human body through inhalation or direct skin inoculation by trauma or ingestion and result in pulmonary, cutaneous, and gastrointestinal mucormycosis, respectively, in immunocompromised hosts. Patients with uncontrolled diabetes, hematological malignancies, high-dose glucocorticoid therapy, iron overload, and organ transplantation are at high risk of acquiring mucormycosis. The second wave of severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] affected India severely with the highest number of cases and deaths compared to all other countries. Additionally, the country was affected by emergence of rare but life-threatening mucormycosis. Currently, many coronavirus disease 2019 patients with underlying risk factors such as uncontrolled diabetes, high-dose steroid therapy, and exposure to mechanical ventilation have developed mucormycosis. Inhalation is the most common mode of transmission that results in colonization of sporangiospores in the nose. In immunocompromised host, sporangiospores germinate, and subsequently form hyphae. These hyphae invade into tissues, and produce tissue infarction, necrosis, and thrombosis. Angioinvasion causes hematogenous dissemination to many organs, predominantly to brain, that result in rhino-orbital-cerebral mucormycosis. Clinical characteristics, radio imaging, fungal culture, histopathology, and molecular techniques are the key diagnostic methods. Surgical intervention and aggressive antifungal therapy are the main management strategies. Amphotericin B is the drug of choice for treatment of mucormycosis, whereas posaconazole or isavuconazole is used for step-down therapy and salvage therapy.

摘要

毛霉病是一种罕见但危及生命的机会性真菌感染,由一组属于毛霉目接合菌纲的霉菌引起。这些真菌存在于土壤、腐烂植被和有机物等环境中。环境中的孢子囊孢子通过吸入、外伤直接接种皮肤或经口摄入进入人体,分别在免疫功能低下的宿主中导致肺、皮肤和胃肠道毛霉病。患有未控制的糖尿病、血液系统恶性肿瘤、大剂量糖皮质激素治疗、铁过载和器官移植的患者感染毛霉病的风险很高。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的第二波疫情对印度造成了严重影响,与所有其他国家相比,病例数和死亡人数最多。此外,该国还受到了罕见但危及生命的毛霉病出现的影响。目前,许多患有未控制的糖尿病、大剂量类固醇治疗和接受机械通气等潜在危险因素的2019冠状病毒病患者都患上了毛霉病。吸入是最常见的传播方式,可导致孢子囊孢子在鼻腔定植。在免疫功能低下的宿主中,孢子囊孢子发芽,随后形成菌丝。这些菌丝侵入组织,产生组织梗死、坏死和血栓形成。血管侵袭导致血行播散至许多器官,主要是大脑,从而导致鼻眶脑毛霉病。临床特征、影像学检查、真菌培养、组织病理学和分子技术是关键的诊断方法。手术干预和积极的抗真菌治疗是主要的治疗策略。两性霉素B是治疗毛霉病的首选药物,而泊沙康唑或艾沙康唑用于降阶梯治疗和挽救治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c9/9008285/e7d003232fa4/IJCIIS-12-38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c9/9008285/2167464f2be0/IJCIIS-12-38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c9/9008285/e7d003232fa4/IJCIIS-12-38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c9/9008285/2167464f2be0/IJCIIS-12-38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c9/9008285/e7d003232fa4/IJCIIS-12-38-g002.jpg

相似文献

1
Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.新冠疫情后患者中罕见的危及生命的机会性毛霉菌病风暴:两种病原体的故事
Int J Crit Illn Inj Sci. 2022 Jan-Mar;12(1):38-46. doi: 10.4103/ijciis.ijciis_48_21. Epub 2022 Mar 24.
2
Mucormycosis.毛霉菌病。
Semin Respir Crit Care Med. 2020 Feb;41(1):99-114. doi: 10.1055/s-0039-3401992. Epub 2020 Jan 30.
3
Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019.鼻眶脑型毛霉菌病作为2019冠状病毒病的一种并发症
World J Virol. 2022 Sep 25;11(5):293-299. doi: 10.5501/wjv.v11.i5.293.
4
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.打破常规:毛霉病及当前药物治疗选择综述
Ann Pharmacother. 2016 Sep;50(9):747-57. doi: 10.1177/1060028016655425. Epub 2016 Jun 15.
5
Mucor in a Viral Land: A Tale of Two Pathogens.霉菌在病毒之地:两种病原体的故事。
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
6
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.第一部分:毛霉菌病:患病率、危险因素、临床特征和诊断。
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7.
7
Rise of mucormycosis during the COVID-19 pandemic and the challenges faced.新型冠状病毒肺炎大流行期间毛霉病的增多及面临的挑战
Curr Med Mycol. 2023 Mar;9(1):44-55. doi: 10.18502/cmm.2023.345032.1400.
8
Mucormycosis: The Scathing Invader.毛霉病:极具侵袭性的病原体
Indian J Dermatol. 2021 Jul-Aug;66(4):393-400. doi: 10.4103/ijd.ijd_477_21.
9
Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.COVID 相关毛霉病在肾移植受者中的危险因素和结局。
Transpl Infect Dis. 2022 Apr;24(2):e13777. doi: 10.1111/tid.13777. Epub 2022 Jan 31.
10
Rhino-orbital-cerebral mucormycosis.鼻-眶-脑毛霉病。
Curr Infect Dis Rep. 2012 Aug;14(4):423-34. doi: 10.1007/s11908-012-0272-6.

引用本文的文献

1
Maxillary mucormycosis masquerading as an endodontic-periodontal lesion.伪装成牙髓-牙周病变的上颌毛霉菌病
J Indian Soc Periodontol. 2024 Jul-Aug;28(4):484-488. doi: 10.4103/jisp.jisp_89_24. Epub 2025 Jan 6.
2
Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study.基于一种新的手术分期系统的新冠相关鼻眶脑毛霉菌病全手术清创结果:一项队列研究
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):298-308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29.
3
A 17-year-old student with ankle sprain to leg amputation.

本文引用的文献

1
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.新型冠状病毒相关毛霉菌病的发病机制与病理学:新进展及原因
Curr Fungal Infect Rep. 2022;16(4):206-220. doi: 10.1007/s12281-022-00443-z. Epub 2022 Sep 29.
2
Mucormycosis: A deadly black fungus infection among COVID-19 patients in India.毛霉菌病:印度新冠肺炎患者中一种致命的黑色真菌感染。
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100900. doi: 10.1016/j.cegh.2021.100900. Epub 2021 Nov 1.
3
Mucormycosis in COVID-19 pandemic: Risk factors and linkages.2019冠状病毒病大流行中的毛霉病:危险因素及关联
一名17岁的学生从脚踝扭伤发展到腿部截肢。
J Surg Case Rep. 2024 Feb 7;2024(2):rjae003. doi: 10.1093/jscr/rjae003. eCollection 2024 Feb.
4
The Impact of COVID-19 Infection on Miscellaneous Inflammatory Disorders of the Gastrointestinal Tract.2019冠状病毒病感染对胃肠道其他炎症性疾病的影响
Gastroenterol Clin North Am. 2023 Mar;52(1):115-138. doi: 10.1016/j.gtc.2022.10.002. Epub 2022 Oct 7.
5
Post-COVID-19 Cerebral Pheohyphomycosis due to : A Middle Eastern Replica of Post-COVID-19 Mucormycosis?新型冠状病毒肺炎后由 引起的脑暗色丝孢霉病:新型冠状病毒肺炎后毛霉病的中东翻版?
J Glob Infect Dis. 2022 Nov 1;14(4):173-174. doi: 10.4103/jgid.jgid_105_22. eCollection 2022 Oct-Dec.
Curr Res Microb Sci. 2021 Dec;2:100057. doi: 10.1016/j.crmicr.2021.100057. Epub 2021 Aug 8.
4
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
5
Mucormycosis: A killer in the shadow of COVID-19.毛霉菌病:新冠疫情阴影下的杀手
J Mycol Med. 2021 Sep;31(3):101161. doi: 10.1016/j.mycmed.2021.101161. Epub 2021 May 31.
6
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.ECMM/ISHAM 关于中低收入国家 COVID-19 相关毛霉菌病临床管理的建议。
Mycoses. 2021 Sep;64(9):1028-1037. doi: 10.1111/myc.13335. Epub 2021 Jul 26.
7
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections.2019年冠状病毒病住院患者的细菌和真菌感染特征以及与医疗保健相关感染相关的因素
Open Forum Infect Dis. 2021 May 5;8(6):ofab201. doi: 10.1093/ofid/ofab201. eCollection 2021 Jun.
8
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?新冠病毒感染患者中毛霉菌病发病率上升:在第二波疫情期间,这对印度来说是另一个挑战?
Lancet Respir Med. 2021 Aug;9(8):e77. doi: 10.1016/S2213-2600(21)00265-4. Epub 2021 Jun 3.
9
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.当未控制的糖尿病与重症 COVID-19 相遇:毛霉菌病的完美风暴。
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
10
COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?COVID-19 诱发易感患者发生毛霉菌病:发展中国家的一种新现象?
BMJ Case Rep. 2021 Apr 27;14(4):e241663. doi: 10.1136/bcr-2021-241663.